LEAWOOD, Kan., March 8, 2017 /PRNewswire/ — Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of innovative biopharmaceutical products for companion animals, plans to present at the Barclays Capital Global Healthcare Conference on Thursday, March 16, 2017 at 9:00 a.m. ET in Miami.

Interested parties may listen to the webcast live or access the audio link for up to 90 days after the meeting. Presentation slides from the conference will also be available in the Aratana Investor Room.

About Aratana Therapeutics
Aratana Therapeutics is a pet therapeutics company focused on licensing, developing and commercializing innovative biopharmaceutical products for companion animals. Aratana believes that it can leverage the investment in the human biopharmaceutical industry to bring therapeutics to pets in a capital and time efficient manner. The Company’s pipeline includes therapeutic candidates targeting pain, inappetence, cancer, viral diseases, allergy and other serious medical conditions.  Aratana believes the development and commercialization of these therapeutics will permit veterinarians and pet owners to manage pets’ medical needs safely and effectively, resulting in longer and improved quality of life for pets. For more information, please visit www.aratana.com.

For investor inquires:
Craig Tooman
[email protected] 
(913) 353-1026

For media inquiries:
Rachel Reiff
[email protected]
(913) 353-1050


To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/aratana-therapeutics-to-present-at-barclays-capital-global-healthcare-conference-300420518.html

SOURCE Aratana Therapeutics, Inc.